Clinical Trial Update: Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating transcatheter arterial chemoembolization (TACE) with sorafenib for locally advanced hepatocellular carcinoma (HCC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Chung-Ang University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN